V Simposio de Actualización: SIDA 2000.
Open Access
- 1 January 2001
- journal article
- Published by Autonomous University of Yucatan in REVISTA BIOMÉDICA
- Vol. 12 (1)
Abstract
En verano de 1983, dos años después del reconocimiento del Síndrome de Inmunodeficia adquirida (SIDA) en los Estados Unidos de Norteamérica, fueron identificados los dos primeros casos de SIDA en Yucatán, México (1). En 1985, el desconocimiento de este síndrome, de su impacto epidemiológico y de sus consecuencias, motivaron el inicio de una línea de investigación por parte del Centro de Investigaciones Regionales Dr. Hideyo Noguchi de la Universidad Autónoma de Yucatán.Keywords
This publication has 35 references indexed in Scilit:
- Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal TransmissionNew England Journal of Medicine, 1999
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Elective Cesarean Delivery to Reduce the Transmission of HIVNew England Journal of Medicine, 1999
- Obstetric and Newborn Outcomes in a Cohort of HIV-Infected Pregnant Women: A Report of the Women and Infants Transmission StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected WomenJAMA, 1999
- Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype RecombinantsVirology, 1998
- After AIDS Clinical Trial 076: The Changing Pattern of Zidovudine Use during Pregnancy, and the Subsequent Reduction in the Vertical Transmission of Human Immunodeficiency Virus in a Cohort of Infected Women and Their InfantsThe Journal of Infectious Diseases, 1996
- Effects of perinatal zidovudine on hematopoiesis: a comparison of effects on progenitors from human fetuses versus mothersAIDS, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesCell, 1996
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994